Journal of Endocrinological Investigation

, Volume 12, Issue 11, pp 783–787 | Cite as

Interaction of L-dopa and GHRH on GH secretion in normal men

  • J. Alba-Roth
  • Ch. von Creytz
  • G. Mehltretter
  • J. Schopohl
  • O. A. Müller
  • K. von Werder


To determine how L-dopa stimulates GH secretion, we investigated its interaction with GHRH in vivo. Six normal men were studied on 4 occasions: 1) L-dopa-TRH: 500 mg L-dopa orally followed by 200 µg TRH 60 min later; 2) L-dopa-GHRH-TRH: 100 µg GHRH 1-44 iv 30 min after L-dopa followed by 200 µg TRH iv; 3) GHRH-TRH: 100 µg GHRH iv at 0 min, 30 min later 200 µg TRH iv; 4) TRH test: 200 µg TRH iv as a bolus. After L-dopa-TRH GH-levels increased significantly from 0.6 µg/l to 25.8 ± 9.6 (SE) µg/l at 60 min. Only a slight TSH and no PRL increase was observed after L-dopa-TRH. After L-dopa-GHRH-TRH the GH-increase was significantly higher (45.7 ± 11.1 µg/l) compared to L-dopa-TRH alone. GHRH-TRH increased GH-levels to 52.5 ± 12.1 µg/l, which was not significantly different from the GH-levels obtained when L-dopa-GHRH-TRH were given. TRH increased serum TSH and PRL to 6.3 ± 0.7 µU/ml and 715 ± 136 µU/ml, respectively, which was significantly higher compared to the TSH responses after L-dopa-TRH. The PRL and TSH increase after TRH only was also higher (TSH-max: 5.7 ± 0.5 µU/ml; PRL-max: 899 ± 154 µU/ml) compared to the TSH and PRL responses after L-dopa-TRH. Our results show that the combination of L-dopa with GHRH leads to the same GH response as GHRH only. However, both responses are significantly higher than the one after L-dopa alone. This observation indicates that the stimulatory effect of L-dopa on GH secretion is mediated by endogenous GHRH. The inhibition of the TSH and PRL response to TRH after L-dopa administration, however, is due to the direct action of the L-dopa metabolite dopamine on the anterior pituitary.


Growth hormone-releasing hormone (GHRH) thyrotropin-releasing hormone (TRH) L-dopa growth hormone TSH prolactin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boyd A.E., Lebovitz H.E., Pfeiffer J.B. Stimulation of human-growth-hormone secretion by L-dopa. N. Engl. J. Med. 253: 1425, 1970.CrossRefGoogle Scholar
  2. 2.
    Dieguez C., Valcavi R., Page M. D., Zini M., Casoli P., Edwards C.A., Portioli I., Scanion M.F. L-dopa releases GH via a GRF dependent mechanism in normal human subjects, whereas arginine, clonidine and adrenalin plus propanolol do not. 3rd Meeting of the European Neuroendocrine Association, London, 1987, Abstract 126.Google Scholar
  3. 3.
    Delitala G., Palermo M., Ross R., Coy D., Besser M., Grossman A. Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man. Neuroendocrinology 45: 243, 1987.PubMedCrossRefGoogle Scholar
  4. 4.
    Vance M.L., Kaiser D.L., Frohman L. A., Rivier J., Vale W. W., Thorner M. O. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. J. Clin. Endocrinol. Metab. 64: 1136, 1987.PubMedCrossRefGoogle Scholar
  5. 5.
    Penny E.S., Penman E., Price J., Rees L.H., Sopwith A.M., Wass J.A.H., Lytras N., Besser G.M. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Br. Med. J. 289: 453, 1984.CrossRefGoogle Scholar
  6. 6.
    Sopwith A.M., Penny E.S., Besser G.M., Rees L.H. Stimulation by food of peripheral plasma immunoreactive growth hormone releasing factor. Clin. Endocrinol. (Oxf.) 22: 337, 1985.CrossRefGoogle Scholar
  7. 7.
    Von Werder K. Wachstumshormone und Prolaktinsekretion beim Menschen. Urban und Schwarzenberg, Munich-Berlin-Wien, 1975.Google Scholar
  8. 8.
    Wass J.A.H. Growth hormone neuroregulation and the clinical relevance of somatostatin. Clin. Endocrinol. Metabol. 12: 695, 1983.CrossRefGoogle Scholar
  9. 9.
    Page M.D., Dieguez C., Valcavi R., Edwards C., Hall R., Scanion M.F. Growth hormone (GH) responses to arginrne and L-dopa alone and after GHRH pretreatment. Clin. Endocrinol. (Oxf.) 28: 551, 1988.CrossRefGoogle Scholar
  10. 10.
    Marcovitz S., Goodyear G.C., Guyda H., Gardiner R.J., Hardy J. Comparative study of human fetal, normal adult and somatotropic adenoma pituitary function in tissue culture. J. Clin. Endocrinol. Metab. 54: 6, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Delitala G., Tomasi P., Virdis R. Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications. J. Endocrinol. Invest. 11: 441, 1988.PubMedCrossRefGoogle Scholar
  12. 12.
    Dieguez C., Page M.D., Scanion, M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. (Oxf.) 28: 109, 1988.CrossRefGoogle Scholar
  13. 13.
    Losa M., Stalla G.K., Müller O.A., von Werder K. Human pancreatic growth hormone releasing factor (hpGRF): dose reponse of GRF-and GH-levels. Klin. Wochenschr. 61: 1249, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin of the release of TSH induced in man by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.PubMedCrossRefGoogle Scholar
  15. 15.
    Alba-Roth J., Müller O.A., Schopohl J., von Werder K. Arginine stimulates growth hormone secretion by suppression of endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.PubMedCrossRefGoogle Scholar
  16. 16.
    Chihara K., Kashio Y., Kita T., Okimura Y., Kaji H., Abe H., Fujita T. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. J. Clin. Endocrinol. Metab. 62: 466, 1986.PubMedCrossRefGoogle Scholar
  17. 17.
    Masuda A., Shibasaki T., Imaki T., Demura H., Shizume K. The manner of GHRH involvement in GH stimulation test in man. 1st International Congress of Neuroendocrinology, San Francisco, USA, Abstract 186. 1986.Google Scholar
  18. 18.
    Tapanainen P., Knip M., Lautala P., Leppäluoto J. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men. J. Clin. Endocrinol. Metab. 67: 845, 1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Donnadieu M., Evain-Brion D., Tonon M.C., Vaudry H. Job J.C. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children. J. Clin. Endocrinol. Metab. 60: 1132, 1985.PubMedCrossRefGoogle Scholar
  20. 20.
    Giusti M., Mazzochi P., Sessarego P., Mignone D., Lomeo A., Monachesi M., Giordano G. Effects of GRF (1–40) and Domperidone on GH secretion in normal men. Clin Endocrinol. (Oxf.) 21: 339, 1984.CrossRefGoogle Scholar
  21. 21.
    Looij J.R., Nieuwenhuijzen Kruseman A.C., Mudde A.H., Frölich M., Piaditis G.P., Hodgkinson S.C., McLean C., Grossman A., Coy D.H., Rees L.H., Lowry P.J., Besser G.M. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol. (Oxf.) 24: 149, 1986.CrossRefGoogle Scholar
  22. 22.
    Schopohl J., Losa M., König A., Müller O.A., Stalla G.K., von Werder K. Combined pituitary function-test with four hypothalamic releasing hormones. Klin. Wochenschr. 64: 314, 1986.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1989

Authors and Affiliations

  • J. Alba-Roth
    • 1
  • Ch. von Creytz
    • 1
  • G. Mehltretter
    • 1
  • J. Schopohl
    • 1
  • O. A. Müller
    • 1
  • K. von Werder
    • 2
  1. 1.Medizinische Klinik InnenstadtMunich 2
  2. 2.Schlosspark KlinikBerlin 19Federal Republic of Germany

Personalised recommendations